Literature DB >> 33844360

Trend in Stereotactic Radiation Therapy Use for Management of Bone and Brain Metastases in Patients with Renal Cell Carcinoma in Australia.

Wee Loon Ong1,2,3,4,5, Shankar Siva1,6, Roger L Milne7,8,9,10, Farshad Foroudi2, Jeremy L Millar5,11.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33844360      PMCID： PMC8265356          DOI： 10.1002/onco.13792

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  4 in total

1.  Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S.

Authors:  Marco Paciotti; Andrew L Schmidt; Praful Ravi; Rana R McKay; Quoc-Dien Trinh; Toni K Choueiri
Journal:  Oncologist       Date:  2021-03-24

Review 2.  Systemic Therapy for Metastatic Renal-Cell Carcinoma.

Authors:  Toni K Choueiri; Robert J Motzer
Journal:  N Engl J Med       Date:  2017-01-26       Impact factor: 91.245

3.  Stereotactic radiosurgery for managing brain metastases in Victoria, 2012-2017.

Authors:  Wee Loon Ong; Therese Ming Jung Kang; Gishan Ratnayake; Morikatsu Wada; Jeremy Ruben; Sashendra Senthi; Roger L Milne; Jeremy L Millar; Farshad Foroudi
Journal:  Med J Aust       Date:  2020-04-06       Impact factor: 7.738

4.  Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.

Authors:  Stephanie G C Kroeze; Corinna Fritz; Jana Schaule; Shankar Siva; Klaus H Kahl; Nora Sundahl; Oliver Blanck; David Kaul; Sonja Adebahr; Joost J C Verhoeff; Georgios Skazikis; Falk Roeder; Michael Geier; Franziska Eckert; Matthias Guckenberger
Journal:  BJU Int       Date:  2020-11-19       Impact factor: 5.588
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.